Assessing the Impact of Expert Knowledge on ICH M7 (Q)SAR Predictions

Application of (Q)SAR and Expert Knowledge for ICH M7 Impurity ClassificationПодробнее

Application of (Q)SAR and Expert Knowledge for ICH M7 Impurity ClassificationПодробнее

Applying Expert Knowledge for ICH M7 Classification - Session 2Подробнее

ICH M7 - Risk assessment for mutagenic impurities and control strategiesПодробнее

Applying Expert Knowledge for ICH M7 Assessments Session 3 August 4th 2020Подробнее

Applying Expert Knowledge for ICH M7 Impurity Classification - Session 1Подробнее

Introduction to Using (Q)SAR for the Assessment of Potential Mutagenicity of Drug ImpuritiesПодробнее

ICH M7(R1) – Chemistry and Manufacturing Control (CMC) Perspective on Hazard AssessmentПодробнее

Predictive Toxicology using (Q)SARПодробнее

[Multidisciplinary] ICH M7 AddendumПодробнее

Applying Expert Knowledge for Nitrosamine Carcinogenicity AssessmentПодробнее

Understanding concepts of ICH M7 (R1) Part 1Подробнее

[Multidisciplinary] M7(R2) / Q&As_ENGПодробнее

(Q)SAR Assessment Framework from the National Institute of Health Sciences (NIHS), JapanПодробнее

Laboratory Developed TestsПодробнее

ICH Q&A Review: Dalia Global and MultiCASEПодробнее

Risk assessment of potentially mutagenic impurities in drug products approved in BrazilПодробнее

How does evidence-based decision making assist Expert Review?Подробнее